A drug that treats both ADHD & Tourette's Disorder - Clonidine
- Jan 13
- 2 min read
It is very common for children diagnosed with ADHD to also experience tics (sudden, repetitive, and involuntary movements or vocalizations). Medical research indicates that approximately 30% to 50% of children with ADHD may also have a chronic tic disorder, such as Tourette Syndrome. The symptoms of both conditions are often worse during times of stress or excitement. When a child has both ADHD and tics, treatment must be carefully chosen to manage both sets of symptoms without making either one worse.
Clonidine is a medication that belongs to a class called α2A-adrenergic agonists. Clonidine acts on specific receptors in the prefrontal cortex—the part of the brain responsible for executive functions, attention, and impulse control. By boosting the regulatory power of this area, it can help manage core ADHD symptoms like hyperactivity and impulsivity. However, evidence shows that traditional stimulant medications remain the more efficacious option.
Clonidine is often considered an alternative because it is also effective at reducing the frequency and severity of tics. It accomplishes this by both strengthening the prefrontal cortex which can inhibit tics, and also by calming the central nervous system due to its sedative side effect. In addition, evidence also suggests that clonidine can help with sleep disturbances which is common in ADHD.
The most frequent side effect is sedation or drowsiness, which is why it is often prescribed to be taken at night. Other common issues include dizziness and a drop in blood pressure or heart rate. Because clonidine affects the cardiovascular system, there is a need for regular monitoring of their blood pressure and heart rate. It is also essential that clonidine is never stopped abruptly; it must be gradually reduced (tapered) under medical supervision to avoid a potential rebound increase in blood pressure.
A more recent ADHD treatment would be Guanfacine. It targets the same a2A-adrenergic receptors and is thus effective as an option for patients with ADHD and comorbid tics disorder. Its more selective profile helps reduce, but not eliminate the risk of unwanted side effects like sedation and hypotension. Guanfacine often allows for once-daily dosing, which can be more convenient and simplify adherence compared to the multiple daily dosing typically required for clonidine.


Comments